The vector of anti-WT1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human WT1. The T cells are genetically modified through transduction with a retroviral vector expressing WT1-specific T cell receptor. And the vector product was designed for the treatment of AML, CML, MDS and in breast, colon and ovarian cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C584||Lenti-WT1 T cell receptor (Cysteine-modified) Viral Particle|
|CAR-YF104||Anti-WT1 (CBL-YF034) h(4-1BB-CD3ζ) CAR, pCDCAR1|
|TCR-L267||Human anti-WT1 T cell receptor (D13.0.1), pCDTCR1|
|CAR-YF105||Anti-WT1 (CBL-YF034) h(CD28-CD3ζ) CAR, pCDCAR1|
|VP-TCR-C594||Lenti-WT1 T cell receptor (Codon optimized) Viral Particle|
|TCR-L124||Murinized (from Human) anti-WT1 (RMFPNAPYL) T Cell Receptor, pMP71|
|TCR-C259Z||Human anti-WT1 T cell receptor (TAK1), pCDTCR1|
|TCR-L125||Human anti-WT1 (CMTWNQMNL) T Cell Receptor, pMP71|
|TCR-L123Z||Murinized anti-WT1 (aa126-134) T cell receptor, pCDTCR1|
|VP-TCR-C592||Lenti-WT1 T cell receptor Viral Particle|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved